GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments.

Biotechnology

GENFIT

Pascal Prigent

Catherine Larue

Katharina Staufer

Tom Huijbers

Thomas Baetz

Stefanie Magner

Dean Hum

Laurent Lannoo

Meriam Kabbaj

Émilie Desodt

Jean-Christophe Marcoux

Carol Addy

Pascal Caisey

The board of directors at GENFIT has a history of experience in the pharmaceutical industry, with members coming from companies such as Eli Lilly and Company, Celgene, and Johnson & Johnson. In addition, the board has members with experience in military service and academia. The board members have a variety of educational backgrounds, including marketing and communication, business/commerce, French language and literature, and biology.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at GENFIT

Leadership Team

CEO and Executive Team